Optimising clinical trial outsourcing partnerships in emerging markets

In Partnering and Corporate strategy by Freya SmaleLeave a Comment

download, emerging markets

Why Outsource Clinical Trials …in Emerging Markets ?
General reasons: less investment, specific expertise, company strategy, etc.
But what about emerging markets: Less costly, Faster recruitment, better retention, Research -naïve population, Specific populations, Universal regulations (ICH-GCP)

Optimising clinical trial outsourcing partnerships in emerging markets

· Building mutually beneficial relationships between vaccine manufacturers and CROs

· Support structures for Pharma/Biotech companies from clinical trials to market supply – what are the best practice benchmarks?

· How Pharma/Biotech can increase collaborative efforts with CROs to increase efficiency

Dr Eduardo Motti, Regional Head of Clinical Operations, Latin America, Pfizer

For the full presentation, click here >

For more information about the topics discussed, please click here >

For more updates on the vaccines industry, follow us on Twitter: @vaccinenation or join our LinkedIn group: Vaccine Nation

Leave a Comment

Current ye@r *